Who Profits From High Prescription Drug Prices Wealth Daily High drug prices affect everyone—those who pay out-of-pocket, those with private insurance, and even those on Medicare Part D Some may skip filling prescriptions because they can't afford them In a recent poll conducted by the Pew Research Center, health care was the third most important issue for voters in the presidential race, a concern voiced by 57% of respondents who were interviewed
Who Profits From High Prescription Drug Prices Instead of tackling the root causes, these price-setting boards could exacerbate the dominance of pharmacy benefit manager owned pharmacies at the expense of community pharmacies Rebates for drug prices, which are effectively discounts, are negotiated by pharmacy benefit managers, not insurers These PBMs, authors said, are incentivized to steer patients toward formulary drugs Project 2025’s agenda to put profits ahead of patients would hurt American consumers for decades to come Last month, the role of PBMs in rising healthcare costs was at the forefront of a Congressional hearing, the third in a series of hearings focused on PBMs that started last year Politicians displayed
Comments are closed.